Biopharma Opportunities and Obligations
Gain insights on the value of public/private partnership in developing platforms for pandemic preparedness.
Continuing education and additional job training are key to bridge biopharma skills gaps, grow talent and provide resilient biopharmaceutical supply chains. Read this article for new insights from NIBRT, Teesside University’s National Horizons Centre (NHC) and other leaders to learn how new approaches for talent sourcing and to fill specialized-skills gaps can grow biomanufacturing resilience.
Understand how you can ensure your staff is up to date on today’s complex bioprocessing techniques and technologies.
Lower costs, improve outcomes and alter the landscape of the global pharmaceutical market.
Understand current challenges and trends influencing design considerations for viral vector manufacturing facilities and how they can impact companies developing cell and gene therapies.
The biopharma industry offers big rewards – but it poses big risks, too. Rather than fearing the unknown, the concept of optionality can help you better manage it.
Increasing mRNA capabilities and capacity for growing market needs.
Designing agile manufacturing with an integrated drug substance/drug product ecosystem.